The Hain Celestial Group (HAIN) is a natural and organic food and personal-care products company. Six attributed analyst price targets were reviewed. Barclays analyst Andrew Lazar lowered his target to $0.30 (Underweight) in October 2026; Jefferies' Kaumil Gajrawala set $0.81 (Hold) in July 2026; Mizuho and Stephens each set $1.00, while Stifel also moved to $1.00 in early 2026. Maxim Group holds the most optimistic view at $3.00 (Buy), reiterated in September 2026. The average of these six targets is about $1.19, rounded to a $1.20 central target, within a $0.30 to $3.00 range.
Several of these targets predate the sharp deterioration in late 2026, when shares collapsed toward penny-stock levels. The wide range reflects genuine disagreement: cautious analysts emphasize revenue declines, competitive pressure, and leverage, while the most bullish view assumes a restructuring-driven recovery that materially restores profitability and balance-sheet strength. No single target should be treated as more likely than another, and the $1.20 mean is a mathematical average, not an official published consensus. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock has been trading near $0.12 to $0.14, down roughly 90% over the past year, with a market capitalization of only about $11 million. At approximately $0.14, the move to $1.20 represents an upside of roughly 750%, which is a very large required move. The path would likely depend first on stabilizing the balance sheet rather than on operating fundamentals alone. Hain has reported declining revenue, with fiscal 2026 revenue of roughly $1.35 billion, and the company disclosed that its auditor expressed doubt about its ability to continue as a going concern. Any sustained move higher would likely require resolving a substantial debt maturity, restoring compliance with Nasdaq's $1.00 minimum bid price rule, and convincing the market that the remaining North American business can return to growth.
The clearest supports are balance-sheet related. The company reached an agreement to sell its International business to AURELIUS for roughly $323 million, with net proceeds intended to reduce debt, and outlined about $16 million in annualized cost savings tied to a smaller, North America-focused footprint. A successful refinancing or extension of maturing debt, combined with a reverse stock split to restore the share price above $1.00, could reduce immediate liquidity and delisting overhangs. Any stabilization in revenue or signs that the remaining snacking and wellness portfolio is regaining share would bolster the more optimistic targets. From what I see, the restructuring steps appear central to any potential recovery.
The obstacles are substantial. Bloomberg reported that the company was weighing a possible Chapter 11 filing, and the auditor's going-concern warning signals material uncertainty. Debt maturing in December 2026 remains unresolved, and the shares trade far below Nasdaq's $1.00 minimum bid price, forcing the company to consider a reverse split that often precedes further selling pressure. Continued revenue contraction, competitive pressure in natural and organic food, and the loss of the divested International business all reduce the earnings base that any meaningful re-rating would require. In an equity-restructuring scenario, existing shareholders could face severe dilution or see their interests largely wiped out.
The stock is trading near its 52-week low of roughly $0.12, far below the 52-week high of about $1.48. The $1.00 Nasdaq bid-price threshold now functions as a critical resistance level and regulatory milestone, while the prior low near $0.12 is the key downside support. Because shares have fallen below $1.00 for an extended period, the dominant market-structure question is not trend direction but whether the listing can be preserved, which adds binary event risk on top of ordinary price volatility. I’m watching this closely as the binary risks around listing compliance could dominate near-term moves.
Analyst price targets generally reflect a roughly 12-month research horizon, though the wide $0.30 to $3.00 dispersion here signals very different assumptions about survival and recovery. Investors should monitor the resolution of the December 2026 debt maturity, any refinancing announcement, the company's plan for Nasdaq compliance (including a potential reverse stock split), and the closing of the International business sale. Quarterly results, updates on the going-concern warning, and any Chapter 11 or restructuring news are the most consequential near-term items.
Reaching $1.20 would require Hain Celestial to rise roughly 750% from recent levels, an extraordinary move for a company facing a going-concern warning, unresolved near-term debt maturities, and Nasdaq delisting pressure. The $1.20 figure is simply the average of six widely divergent analyst targets ($0.30 to $3.00), several of which were set before the stock's late-2026 collapse. The most bullish scenarios hinge on a successful deleveraging and restructuring, while the most cautious assume existing equity is substantially impaired. Investors should weigh the wide analyst disagreement and monitor refinancing, listing-compliance, and restructuring developments rather than treating any single target as a reliable price forecast.
In my analysis of event-driven names like this, I find Tickeron’s AI Daily Buy/Sell Signals helpful for spotting shifts in momentum when headlines move quickly. The tool monitors thousands of stocks with AI-driven technical and market-condition analysis, which can complement manual review of filings and news flow without replacing it. This approach has been useful for tracking volatile situations where traditional signals may lag.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HAIN moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend. In 35 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HAIN as a result. In 70 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HAIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for HAIN entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 62 cases where HAIN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for HAIN just turned positive on November 04, 2026. Looking at past instances where HAIN's MACD turned positive, the stock continued to rise in 28 of 40 cases over the following month. The odds of a continued upward trend are 70%.
Following a +12.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where HAIN advanced for three days, in 160 of 240 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
HAIN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.088) is normal, around the industry mean (6.914). P/E Ratio (-0.044) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (1.223) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.039) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. HAIN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HAIN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of organic snack food and personal care products
Industry FoodMajorDiversified